Cargando…
Spontaneous haemorrhagic cholecystitis secondary to the use of novel anticoagulants (rivaroxaban)
Haemorrhagic cholecystitis is a rare complication of acute cholecystitis. It carries a high risk of morbidity and mortality. Risk factors for haemorrhagic cholecystitis include cholelithiasis, trauma, malignancy and the use of anticoagulants. There have only been a few reported cases of haemorrhagic...
Autores principales: | Kurian, Merina, Lim, Chee Khong, Kler, Prabhjoyt, Chow, Bing Lun, Chacko, Cyril Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621570/ https://www.ncbi.nlm.nih.gov/pubmed/37928697 http://dx.doi.org/10.1259/bjrcr.20220128 |
Ejemplares similares
-
Haemorrhagic cholecystitis treated with endovascular embolization
por: Morrow, Joseph, et al.
Publicado: (2023) -
Persevering With Prone Ventilation in Coronavirus Disease 2019 Pneumonia
por: Byrne, Matthew, et al.
Publicado: (2020) -
Spontaneous rupture and hematoma of the sartorius muscle secondary to rivaroxaban therapy
por: Ardebol, Javier, et al.
Publicado: (2020) -
Literature review and case series of haemorrhagic cholecystitis
por: Tarazi, M, et al.
Publicado: (2019) -
A case of haemorrhagic cholecystitis with no risk factors
por: Khan Hotak, Mirwais, et al.
Publicado: (2021)